Clinical trials: Lung Volume
Prolonged Air Leak
IBV Valve System for the Treatment of Prolonged Air Leak Under HDE H060002 - Post Approval Study
Study to collect post-market safety data for HUD IBV Valve System, a device to control prolonged air leaks of the lung, or significant air leaks that are likely to become prolonged air leaks following lobectomy, segmentectomy, or…
- Trial name
- HUD-PAS (NCT01166516)
- Testing
- Treatment with HUD IBV Valve System
- Where
- 13 sites in United States
- Volunteers
- 32 people
- Sponsor
- Olympus Corporation of the Americas
Advanced Upper Lobe Predominant Emphysema
Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema
The purpose of the study is to evaluate the efficacy and safety of the 20 mL BLVR System in treating patients with advanced upper lobe predominant emphysema.
- Trial name
- NCT00716053
- Testing
- BLVR
- Volunteers
- 225 people
- Sponsor
- Aeris Therapeutics
Emphysema
Zephyr Valve Registry (ZEVR)
The purpose of this Post-Approval Registry is to gather ongoing safety and effectiveness assessment of the Zephyr Valve treatment in a real-world setting.
- Trial name
- ZEVR (NCT04186546)
- Testing
- Zephyr Valve Procedure
- Where
- 11 sites in United States
- Volunteers
- 150 people
- Sponsor
- Pulmonx Corporation
Asthma
Inspiratory Flow Using the Osmohaler
The OsmohalerTM is a registered device in Australia. It is used to deliver a dry powder a commercial preparation of mannitol registered as AridolTM to test if a person has irritable airways such as active asthma.
- Trial name
- NCT00531414
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Syntara
Eosinophilic Asthma, Asthma; Eosinophilic
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma to evaluate improvements in lung function, asthma control, and quality of life.
- Conditions
- Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Attack
- Trial name
- EXHALE-4 (NCT05748600)
- Testing
- Dexpramipexole Dihydrochloride
- Where
- 335 sites in United States, Argentina and 16 more
- Volunteers
- 600 people
- Sponsor
- Areteia Therapeutics
Cystic Fibrosis
Cystic Fibrosis (CF) Flow Rates Study
We wish to measure the inspiratory flow and volumes generated by the subjects inhaling from a spirometer with a high resistance dry powder inhaler in series in subjects with cystic fibrosis.
- Trial name
- NCT00779077
- Volunteers
- 25 people
- Sponsor
- Syntara
Pulmonary Arterial Hypertension
Assessmet of Patients With PAH Right Ventricular Volume
The primary endpoint of this study is the percent difference between the VentriPoint Medical System (VMS) and cMRI for estimating the end diastolic and end systolic right ventricular volumes (RVEDV and RVESV) in subjects with…
- Trial name
- NCT01557582
- Testing
- Ventripoint Medical System
- Where
- 7 sites in United States, Canada
- Volunteers
- 103 people, healthy volunteers welcome
- Sponsor
- VentriPoint Diagnostics Ltd.
Monitoring of Regional Distribution of Ventilation, Monitoring of Lung Volume
Prospective, Open, Non-interventional Study to Assess the Ability of an Electrical Impedance Tomograph (PlumoVista 500)
This observational PMCF study will be conducted to generate and gather clinical data from the intended target population of pediatric patients.
- Trial name
- PV500ped (NCT04873999)
- Where
- Germany
- Volunteers
- 23 people, healthy volunteers welcome
- Sponsor
- Drägerwerk AG & Co. KGaA